Stem Cell- and Cell-Based Therapies for Ischemic Stroke

Stroke is the second cause of disability worldwide as it is expected to increase its incidence and prevalence. Despite efforts to increase the number of patients eligible for recanalization therapies, a significant proportion of stroke survivors remain permanently disabled. This outcome boosted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistor-Cseppentö, Delia Carmen, Jurcău, Maria Carolina, Jurcău, Anamaria, Andronie-Cioară, Felicia Liana, Marcu, Florin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687728/
https://www.ncbi.nlm.nih.gov/pubmed/36421118
http://dx.doi.org/10.3390/bioengineering9110717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687728/
https://www.ncbi.nlm.nih.gov/pubmed/36421118
http://dx.doi.org/10.3390/bioengineering9110717

Ejemplares similares